What is Opus Ksd?
Opus Ksd, Inc. is a specialized medical device manufacturer focused on the development of the SubQ It! bioabsorbable skin closure system. By engineering a disposable stapler specifically for subcutaneous and laparoscopic incisions, the company addresses a critical pain point in modern surgical procedures. The SubQ It! system is engineered to deliver wound closure seven times faster than conventional suturing methods, effectively eliminating the patient discomfort associated with traditional metal staple removal. With FDA clearance already secured, the company is positioned to disrupt the minimally invasive surgery market by offering a solution that prioritizes both clinical efficiency and superior aesthetic outcomes for patients through reduced scarring.
How much funding has Opus Ksd raised?
Opus Ksd has raised a total of $500K across 1 funding round:
Private Equity
$500K
Private Equity (2016): $500K, investors not publicly disclosed
Key Investors in Opus Ksd
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Opus Ksd?
With the recent infusion of capital, Opus Ksd is well-positioned to accelerate its go-to-market strategy and expand its clinical adoption across major hospital networks. The company's roadmap likely involves scaling manufacturing capabilities to meet the anticipated demand for its bioabsorbable technology while potentially exploring further R&D initiatives to broaden its surgical product portfolio. By leveraging this major strategic investment, Opus Ksd aims to solidify its status as a leader in surgical innovation, focusing on long-term value creation for stakeholders and improved patient outcomes in the rapidly evolving field of minimally invasive surgery.
See full Opus Ksd company page
